CVSA Covista Inc. Common Shares
关于 Covista Inc. Common Shares 公司概况(来自维基百科)
Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.
阅读更多
Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.
Before June 2018, the corporation was known as DeVry Education Group Inc. Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017. Adtalem began the process to sell off DeVry University and Keller Graduate School of Management later that year to focus on healthcare professional education. Adtalem subsequently renamed itself Covista in 2026.
History
DeVry Inc. was created in 1987 with the merger of DeVry Institute of Technology (DIT) and the Keller Graduate School of Management. DIT was established in Chicago as the DeForest Training School in 1931 and was acquired by Bell & Howell in 1967. Keller was started by two DIT teachers in 1973; the company acquired DIT from Bell & Howell in 1987. DeVry Inc. went public in 1991, moved to the New York Stock Exchange in 1995, and became known as DeVry Education Group in 2013. The company was previously based in Downers Grove, Illinois.
In 2012, the company moved 150 jobs from its campus in Roscoe Village to a new office in Chicago's West Loop. The company had additional offices in Oak Brook, as of 2013. In 2015, the company opened another office in the West Loop, after the city approved a $1 million subsidy for the company in the form of tax increment financing in 2012.
In November 2013, DeVry Inc. was renamed DeVry Education Group.
Rebranding from DeVry Education Group to Adtalem Global Education
Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017 and began the process to sell off DeVry University and Keller Graduate School of Management later that year. The company stated that the new name signified a renewed focus on professional education in the health care and financial services sectors. Industry analysts characterized the move as an effort to move on from DeVry's legal, financial and reputational challenges.
Inside Higher Ed said, "Even before the new name change, the company has sought to differentiate itself publicly from the rest of the for-profit sector. It has responded to increased regulatory scrutiny -- and negative headlines -- for the sector by announcing self-imposed reforms such as voluntarily limiting the amount of revenue it takes in from federal aid."
The company's headquarters were later relocated from Downers Grove to 500 West Monroe Street in the West Loop Gate. In 2024, Crain's Chicago Business said Adtalem had become "the largest health care educator in the nation during a post-COVID period in which the health care sector has faced severe labor shortages". In November 2024, Adtalem announced plans to expand office capacity by moving to an 84,000-square-foot space in Willis Tower in early 2025. In late 2024, Adtalem partnered with Hippocratic AI to train health care professionals on using artificial intelligence.
Acquisitions and divestitures
Adtalem acquired Becker CPA Review (now known as Becker Professional Education), which prepared students for the Certified Public Accountant exam, in 1996. Adtalem acquired Ross University School of Veterinary Medicine in 2003, Chamberlain University (then Deaconess School of Nursing) in 2005, and American University of the Caribbean in 2011. Adtalem agreed to purchase Walden University for approximately $1.5 billion in September 2020. The agreement required approval by the U.S. Department of Education and the Higher Learning Commission. When the deal closed in August 2021, Adtalem became the largest provider of graduate and undergraduate degrees in nursing.
At the time of the re-branding, approximately half of Adtalem's 225,000 students were based in Brazil and approximately one fifth were studying healthcare. Adtalem went on to divest from the Brazil operations in May 2020.
Adtalem began selling business units unrelated to healthcare education in 2017 and consolidated focus on the industry during 2019–2020, when there was a shortage of health professionals. In 2018, the company sold Carrington College to San Joaquin Valley College, as well as DeVry University to Cogswell Education. In 2019, Kaplan, Inc. acquired Becker's healthcare test preparation assets. Kaplan also agreed to provide Adtalem with U.S. Medical Licensing Examination review programs to Ross University School of Medicine and American University of the Caribbean. In 2022, Colibri Group acquired Becker and OnCourse Learning from Adtalem. Adtalem also sold the Association of Certified Anti-Money Laundering Specialists to the French investment company Wendel. The specific purchase terms were not disclosed, but Adtalem confirmed that its financial services segment, which included ACAMLS, Becker, and OnCourse, sold for $1 billion. Since selling its financial services education business, Adtalem has focused primarily on healthcare education.
Operations
Campuses and enrollment
Adtalem's institutions operated approximately 130 campuses globally in 2018. Twelve of the 90 U.S. campuses were located in Illinois. In 2020, Adtalem's businesses operated 26 campuses in four countries and fifteen U.S. states. Approximately 90,000 students attended schools with a combined 6,100 faculty members. According to Adtalem, 34 percent of the students were Black. The company also claimed to be the largest provider of Master's, doctorate, and nursing degrees for African Americans. As of 2021, approximately 82 percent of the 140,000 students enrolled at Adtalem schools learned via distance education. In 2022, Adtalem operated 27 campuses and offered courses in 209 countries and territories.
Leadership
Stephen Beard, who was previously Adtalem's chief operating officer, became the chief executive officer (CEO) in 2021. He was appointed the chair of the board of directors in November 2024, succeeding Michael W. Malafronte. Beard was included in Time magazine's 2025 "Time100 Health" list of influential people in the healthcare industry.
Chris Begley was the board chair in 2016. Daniel Hamburger and Lisa Wardell have previously held the CEO role. Wardell was appointed in 2016. She was the only Black woman to lead a Fortune 1000 company in 2018, according to Crain's Chicago Business. Wardell was also the board chair in 2019. In 2021, an analysis by the University of Illinois Urbana-Champaign ranked Adtalem in the top five Illinois-based public firms for both gender and racial diversity on the board.
Finances
In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students. In 2017, Adtalem lost approximately $4.6 million from the impacts of Hurricane Irma and Hurricane Maria. The company made a profit of $95.6 million in 2019 and lost $85.8 million in 2020, suffering from enrollment declines during the COVID-19 pandemic. In early 2024, Adtalem was targeted by a short seller and the company announced a $300 million repurchase program. In late 2024, Investor's Business Daily said Adtalem saw an average sales growth of fourteen percent over the last three years. For the 2024 fiscal year, Adtalem repurchased 5.446 million shares for approximately $261 million. In May 2025, the repurchase was completed and a new stock buyback program of up to $150 million through May 2028 was launched.
Controversies
Covista, formerly known as DeVry Education Group, has been the subject of numerous investigations and lawsuits alleging that a variety of false or deceptive practices. While the group has generally denied the allegations, several cases led to multi-million dollar settlements.
In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students.
Months after the FTC settlement, DeVry Education Group rebranded as Adtalem Global Education in May 2018. Adtalem rebranded as Covista in 2026.
For-profit higher education in the United States has been the subject of hearings by the United States Senate Committee on Health, Education, Labor, and Pensions. Specifically regarding DeVry, the Committee found that over half of the students enrolled at DeVry in 2008-2009 withdrew by mid-2010. As of 2015, DeVry spent more on marketing than on student instruction.
As of 2013, DeVry Inc. was under investigation by the Attorneys General of the states of Illinois and Massachusetts.
In 2014, accumulated student loan debt from DeVry University and Keller, its graduate school, had reached approximately $12.1 billion.
A lawsuit filed against DeVry alleged deceptive recruiting practices in violation of federal law.
In January 2016, The Federal Trade Commission filed a lawsuit against DeVry Education Group alleging false or misleading advertising. A class action lawsuit was also filed against DeVry Group in US District Court, Northern District of California claiming breaches of contract, good faith and fair dealing, violations of the California Unfair Trade Practices Act, the California False Advertising Act and the California Consumer Legal Remedies Act, and negligent misrepresentations. A confidential settlement was reached.
In May 2016, a shareholder class action lawsuit was filed against DeVry Group, in the US District Court, Northern District of Illinois. The plaintiffs claimed that defendants made false or misleading statements regarding DeVry University's graduate employment rate and the earnings of DeVry University graduates relative to the graduates of other universities and colleges. The case was settled in 2019 for $27.5 million.
In December 2017, a former administrator filed a civil lawsuit number with the Los Angeles Superior Court, seeking relief for a number of causes of action including Retaliation and Wrongful Termination in Violation of Public Policy for complaining about an incentive-based compensation program that rewarded campus deans for recruiting and enrolling students.
来源:维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗
CVSA 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
CVSA 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
10年表现 收入、净利润、利润率和每股收益趋势
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
财务健康 债务、流动性、偿付能力 — 资产负债表强度
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
资本效率 资产周转率、库存周转率、应收账款周转率
股息 收益率、派息率、股息历史、5年CAGR
| 除息日 | 金额 |
|---|---|
| 2016年11月30日 | $0.1800 |
| 2016年6月1日 | $0.1800 |
| 2015年12月2日 | $0.1800 |
| 2015年6月3日 | $0.1800 |
| 2014年12月3日 | $0.1800 |
| 2014年6月4日 | $0.1700 |
| 2013年12月4日 | $0.1700 |
| 2013年6月5日 | $0.1700 |
| 2012年11月28日 | $0.1700 |
| 2012年6月19日 | $0.1500 |
| 2011年12月6日 | $0.1500 |
| 2011年6月16日 | $0.1200 |
| 2010年12月8日 | $0.1200 |
| 2010年6月11日 | $0.1000 |
| 2009年12月9日 | $0.1000 |
| 2009年6月12日 | $0.0800 |
| 2008年12月10日 | $0.0800 |
| 2008年6月17日 | $0.0600 |
| 2007年12月12日 | $0.0600 |
| 2007年6月14日 | $0.0500 |
CVSA 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
- 强烈买入 4 40.0%
- 买入 5 50.0%
- 持有 1 10.0%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
4 位分析师 · 2026-08-18收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $2.09 | $1.93 | 0.16% |
| 2026年3月31日 | $1.98 | $1.76 | 0.22% |
| 2025年12月31日 | $2.43 | $2.23 | 0.20% |
| 2025年9月30日 | $1.75 | $1.61 | 0.14% |
| 2025年6月30日 | $1.66 | $1.56 | 0.10% |
| 2025年3月31日 | $1.92 | $1.69 | 0.23% |
同行比较(GICS 子行业) 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| CVSA | $4.24B | 17.7 | 9.3% | 12.9% | 17.8% | — |
| DUOL | $8.18B | 20.5 | 38.7% | 39.9% | 35.6% | 72.2% |
| LAUR | $4.81B | 17.8 | 8.6% | 16.6% | 26.2% | — |
| GHC | — | 16.5 | 2.5% | 5.9% | 6.5% | — |
| LOPE | $4.56B | 21.6 | 7.1% | 19.5% | 28.3% | — |
| BFAM | $5.64B | 30.2 | 9.2% | 6.6% | 14.1% | 23.8% |
| LRN | $3.58B | 12.1 | 4.7% | 13.4% | 21.3% | 37.8% |
| MH | $2.62B | 72.1 | 0.07% | 1.7% | 4.6% | 80.9% |
| PRDO | $1.83B | 12.1 | 24.2% | 18.9% | 16.3% | — |
| STRA | $1.84B | 14.8 | 4.0% | 10.0% | 7.6% | — |
| UTI | $1.77B | 28.8 | 14.1% | 7.5% | 20.3% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 16
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.95B | $1.79B | $1.58B | $1.45B | $1.38B | · | · | · | |
| Cost of Revenue | $834M | $771M | $699M | $648M | $660M | · | · | · | |
| SG&A Expense | $731M | $672M | $633M | $586M | $566M | · | · | · | |
| Operating Expenses | $1.57B | $1.45B | $1.37B | $1.28B | $1.31B | · | · | · | |
| Operating Income | $383M | $342M | $217M | $168M | $77M | · | · | · | |
| Interest Expense | $45M | $52M | $64M | $63M | $129M | · | · | · | |
| Interest Income | · | · | · | · | $4M | · | · | · | |
| Other Non-op | $7M | $9M | $11M | $7M | $1M | · | · | · | |
| Pretax Income | $345M | $299M | $164M | $112M | $-51M | · | · | · | |
| Income Tax | $78M | $66M | $26M | $10M | $-16M | · | · | · | |
| Net Income | $252M | $237M | $137M | $93M | $311M | · | · | · | |
| EPS (Basic) | $7.18 | $6.39 | $3.47 | $2.08 | $6.43 | · | · | · | |
| EPS (Diluted) | $7.04 | $6.18 | $3.39 | $2.05 | $6.43 | · | · | · | |
| Shares (Basic) | 35,045,000 | 37,085,000 | 39,413,000 | 44,781,000 | 48,388,000 | · | · | · | |
| Shares (Diluted) | 35,715,000 | 38,334,000 | 40,307,000 | 45,600,000 | 48,388,000 | · | · | · | |
| EBITDA | $383M | $342M | $217M | $168M | $80M | · | · | · |
资产负债表 28
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $406M | $200M | $219M | $272M | $347M | $275M | $416M | $67M | |
| Short-term Investments | · | · | · | · | · | · | · | $9M | |
| Receivables | $167M | $143M | $124M | $100M | $79M | $90M | $69M | · | |
| Prepaid Expense | $75M | $69M | $70M | $102M | $128M | $167M | $97M | $45M | |
| Current Assets | $652M | $416M | $418M | $480M | $557M | $611M | $681M | $390M | |
| PP&E (Net) | $303M | $256M | $249M | $245M | $290M | $302M | $279M | $282M | |
| PP&E (Gross) | $686M | $598M | $575M | $583M | $666M | $663M | $618M | $605M | |
| Accum. Depreciation | $383M | $342M | $326M | $339M | $376M | $362M | $339M | $323M | |
| Goodwill | $961M | $961M | $961M | $961M | $961M | $960M | $310M | $687M | |
| Intangibles | $754M | $765M | $777M | $812M | $874M | $924M | $138M | $293M | |
| Other Non-current Assets | $138M | $129M | $103M | $81M | $119M | $118M | $88M | $83M | |
| Total Assets | $3.01B | $2.75B | $2.74B | $2.81B | $3.03B | $3.66B | $2.27B | $2.39B | |
| Accounts Payable | $125M | $105M | $103M | $82M | $57M | $65M | $39M | $31M | |
| Accrued Liabilities | $94M | $77M | $97M | $106M | $98M | $135M | $97M | $90M | |
| Current Liabilities | $597M | $508M | $488M | $431M | $424M | $497M | $341M | $304M | |
| Capital Leases | $208M | $186M | $168M | $163M | $177M | $156M | $194M | $180M | |
| Deferred Tax | $62M | $32M | $30M | $26M | $26M | $27M | $25M | $25M | |
| Other Non-current Liabilities | $42M | $40M | $39M | $37M | $74M | $58M | $81M | $89M | |
| Total Liabilities | $1.57B | $1.32B | $1.37B | $1.35B | $1.54B | $2.37B | $959M | $1.09B | |
| Long-term Debt | $663M | $553M | $649M | $695M | $839M | $1.61B | $287M | $415M | |
| Total Debt | $663M | $553M | $649M | $695M | $839M | · | · | · | |
| Common Stock | $848.0K | $839.0K | $832.0K | $822.0K | $818.0K | $817.0K | $810.0K | $806.0K | |
| Retained Earnings | $3.03B | $2.78B | $2.54B | $2.40B | $2.31B | $1.96B | $1.97B | $2.03B | |
| Treasury Stock | $2.29B | $2.01B | $1.78B | $1.51B | $1.34B | $1.22B | $1.16B | $1.08B | |
| AOCI | $-2M | $-2M | $-2M | $-2M | $-2M | $-634.0K | $-8M | $-159M | |
| Stockholders' Equity | $1.45B | $1.43B | $1.37B | $1.46B | $1.49B | $1.28B | $1.31B | $1.29B | |
| Liabilities + Equity | $3.01B | $2.75B | $2.74B | $2.81B | $3.03B | $3.66B | $2.27B | $2.39B | |
| Shares Outstanding | 34,033,000 | 35,952,000 | 37,681,000 | 82,232,000 | 81,796,000 | 81,705,000 | 81,021,000 | 52,953,000 |
现金流 16
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41M | $42M | $26M | $14M | $23M | · | · | · | |
| Deferred Tax | $68M | $18M | $11M | $-5M | $-14M | · | · | · | |
| Amort. of Intangibles | $11M | $11M | $36M | $61M | $97M | · | · | · | |
| Restructuring | $6M | $3M | $2M | $19M | $26M | · | · | · | |
| Operating Cash Flow | $470M | $338M | $296M | $192M | $11M | · | · | · | |
| CapEx | $78M | $50M | $49M | $26M | $31M | · | · | · | |
| Investing Cash Flow | $-84M | $-42M | $-48M | $24M | $-552M | · | · | · | |
| Debt Issued | $1.01B | $10M | $2M | $0 | $850M | · | · | · | |
| Net Debt Issued | $112M | $-100M | $-50M | $-151M | $-230M | · | · | · | |
| Stock Repurchased | $240M | $213M | $262M | $123M | $120M | · | · | · | |
| Net Stock Activity | $-240M | $-213M | $-262M | $-123M | $-120M | · | · | · | |
| Financing Cash Flow | $-180M | $-316M | $-302M | $-289M | $-424M | · | · | · | |
| Net Change in Cash | $207M | $-20M | $-54M | $-73M | $-966M | · | · | · | |
| Taxes Paid | $14M | $33M | $31M | $12M | $94M | · | · | · | |
| Free Cash Flow | $393M | $288M | $247M | $166M | $-21M | · | · | · | |
| Levered FCF | $358M | $247M | $193M | $109M | $-106M | · | · | · |
盈利能力 7
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 19.6% | 19.1% | 13.7% | 11.6% | 5.8% | · | · | · | |
| Net Margin | 12.9% | 13.3% | 8.6% | 6.4% | 22.9% | · | · | · | |
| Pretax Margin | 17.7% | 16.7% | 10.3% | 7.7% | -3.2% | · | · | · | |
| EBITDA Margin | 19.6% | 19.1% | 13.7% | 11.6% | 5.8% | · | · | · | |
| ROA | 8.7% | 8.6% | 4.9% | 3.3% | 9.7% | · | · | · | |
| ROE | 17.8% | 16.5% | 10.2% | 6.3% | 21.3% | · | · | · | |
| ROIC | 14.1% | 13.4% | 9.0% | 7.1% | 2.3% | · | · | · |
流动性与偿付能力 5
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 0.8 | 0.9 | 1.1 | 1.3 | · | · | · | |
| Quick Ratio | 1.0 | 0.7 | 0.7 | 0.9 | 1.0 | · | · | · | |
| Debt / Equity | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | · | · | · | |
| LT Debt / Equity | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | · | · | · | |
| Interest Coverage | 8.4 | 6.5 | 3.4 | 2.7 | 0.6 | · | · | · |
效率 2
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | 0.6 | 0.5 | 0.4 | · | · | · | |
| Receivables Turnover | 12.6 | 13.4 | 14.1 | 16.2 | 16.1 | · | · | · |
增长率 9
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.3% | 12.8% | 9.2% | 5.0% | 53.7% | · | · | · | |
| Revenue CAGR 3Y | 10.4% | 9.0% | 20.8% | 18.8% | · | · | · | · | |
| Revenue CAGR 5Y | 16.8% | 15.6% | · | · | · | · | · | · | |
| EPS YoY | 13.9% | 82.3% | 65.4% | -68.1% | 372.8% | · | · | · | |
| EPS CAGR 3Y | 50.9% | -1.3% | 35.6% | · | · | · | · | · | |
| EPS CAGR 5Y | 38.9% | · | · | · | · | · | · | · | |
| Net Income YoY | 6.1% | 73.3% | 46.5% | -70.0% | 344.1% | · | · | · | |
| Net Income CAGR 3Y | 39.2% | -8.6% | 25.0% | · | · | · | · | · | |
| Net Income CAGR 5Y | 29.1% | · | · | · | · | · | · | · |
估值 (TTM) 13
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.95B | $1.79B | $1.58B | $1.45B | $1.38B | · | · | · | |
| Net Income TTM | $252M | $237M | $137M | $93M | $311M | · | · | · | |
| Market Cap | $4.24B | $4.57B | $2.57B | $1.45B | $1.63B | · | · | · | |
| Enterprise Value | $4.50B | $4.93B | $3.00B | $1.87B | $2.12B | · | · | · | |
| P/E | 17.7 | 20.6 | 20.1 | 16.8 | 5.6 | · | · | · | |
| P/S | 2.2 | 2.6 | 1.6 | 1.0 | 1.2 | · | · | · | |
| P/B | 2.9 | 3.2 | 1.9 | 1.0 | 1.1 | · | · | · | |
| P / Cash Flow | 9.0 | 13.5 | 8.7 | 7.2 | 155.9 | · | · | · | |
| P / FCF | 10.8 | 15.9 | 10.4 | 8.8 | -78.8 | · | · | · | |
| EV / EBITDA | 11.7 | 14.4 | 13.8 | 11.1 | 26.3 | · | · | · | |
| EV / FCF | 11.5 | 17.1 | 12.2 | 11.3 | -102.6 | · | · | · | |
| EV / Revenue | 2.3 | 2.8 | 1.9 | 1.3 | 1.5 | · | · | · | |
| Earnings Yield | 5.7% | 4.9% | 5.0% | 6.0% | 17.9% | · | · | · |
损益表 16
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $501M | $487M | $503M | $462M | $457M | $466M | $448M | $417M | $410M | $413M | $393M | $369M | $365M | $369M | $363M | $354M | |
| Cost of Revenue | $217M | $211M | $205M | $201M | $199M | $200M | $187M | $186M | $183M | $175M | $172M | $169M | $164M | $166M | $159M | $160M | |
| SG&A Expense | $188M | $184M | $183M | $176M | $181M | $175M | $157M | $159M | $155M | $157M | $156M | $166M | $153M | $145M | $142M | $146M | |
| Operating Expenses | $406M | $396M | $392M | $377M | $380M | $376M | $344M | $347M | $341M | $351M | $335M | $341M | $325M | $310M | $317M | $331M | |
| Operating Income | $95M | $91M | $111M | $85M | $77M | $91M | $104M | $70M | $69M | $62M | $59M | $28M | $40M | $59M | $46M | $24M | |
| Interest Expense | $10M | $14M | $11M | $11M | $11M | $13M | $14M | $14M | $15M | $17M | $17M | $16M | $15M | $14M | $16M | $18M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | |
| Other Non-op | $3M | $232.0K | $2M | $2M | $3M | $2M | $2M | $3M | $2M | $3M | $4M | $2M | $4M | $4M | $-1M | $761.0K | |
| Pretax Income | $88M | $78M | $102M | $77M | $69M | $79M | $92M | $58M | $56M | $48M | $45M | $15M | $28M | $49M | $29M | $7M | |
| Income Tax | $16M | $20M | $26M | $16M | $14M | $19M | $21M | $12M | $5M | $11M | $8M | $3M | $4M | $389.0K | $4M | $1M | |
| Net Income | $72M | $42M | $76M | $62M | $54M | $61M | $76M | $46M | $49M | $37M | $40M | $11M | $22M | $46M | $25M | $592.0K | |
| EPS (Basic) | $2.12 | $1.21 | $2.14 | $1.71 | $1.50 | $1.64 | $2.03 | $1.22 | $1.26 | $0.95 | $1.00 | $0.26 | $0.51 | $1.02 | $0.54 | $0.01 | |
| EPS (Diluted) | $2.06 | $1.20 | $2.11 | $1.67 | $1.43 | $1.59 | $1.98 | $1.18 | $1.23 | $0.93 | $0.98 | $0.25 | $0.51 | $1.00 | $0.53 | $0.01 | |
| Shares (Basic) | -71,074,000 | 34,283,000 | 35,725,000 | 36,111,000 | -75,211,000 | 37,140,000 | 37,435,000 | 37,721,000 | -80,571,000 | 38,713,000 | 39,872,000 | 41,399,000 | -91,043,000 | 45,125,000 | 45,425,000 | 45,274,000 | |
| Shares (Diluted) | -72,354,000 | 34,782,000 | 36,230,000 | 37,057,000 | -77,409,000 | 38,233,000 | 38,401,000 | 39,109,000 | -82,300,000 | 39,636,000 | 40,787,000 | 42,184,000 | -92,664,000 | 45,801,000 | 46,121,000 | 46,342,000 | |
| EBITDA | · | $91M | $111M | $85M | · | $91M | $104M | $70M | · | $62M | $59M | $28M | · | $59M | $46M | $23M |
资产负债表 27
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $406M | $147M | $56M | $265M | $200M | $219M | $194M | $265M | $219M | $180M | $183M | $262M | · | $315M | $208M | $328M | |
| Receivables | $167M | $173M | $160M | $192M | $143M | $160M | $144M | $169M | $124M | $138M | $131M | $145M | · | $111M | $97M | $109M | |
| Prepaid Expense | $75M | $79M | $81M | $106M | $69M | $66M | $65M | $79M | $70M | $59M | $58M | $61M | · | $103M | $114M | $128M | |
| Current Assets | $652M | $404M | $303M | $567M | $416M | $450M | $407M | $517M | $418M | $388M | $378M | $473M | · | $533M | $423M | $570M | |
| PP&E (Net) | $303M | $277M | $266M | $257M | $256M | $251M | $246M | $245M | $249M | $273M | $260M | $265M | · | $253M | $276M | $282M | |
| PP&E (Gross) | $686M | $649M | $627M | $608M | $598M | $583M | $583M | $574M | $575M | $600M | $605M | $609M | · | $583M | $621M | $646M | |
| Accum. Depreciation | $383M | $372M | $361M | $351M | $342M | $332M | $337M | $329M | $326M | $327M | $345M | $345M | · | $330M | $346M | $364M | |
| Goodwill | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | · | $961M | $961M | $961M | |
| Intangibles | $754M | $757M | $760M | $763M | $765M | $768M | $771M | $774M | $777M | $784M | $792M | $802M | · | $825M | $839M | $855M | |
| Other Non-current Assets | $138M | $137M | $135M | $129M | $129M | $120M | $113M | $108M | $103M | $68M | $66M | $68M | · | $68M | $117M | $121M | |
| Total Assets | $3.01B | $2.74B | $2.61B | $2.87B | $2.75B | $2.79B | $2.72B | $2.82B | $2.74B | $2.72B | $2.70B | $2.79B | · | $2.87B | $2.84B | $3.00B | |
| Accounts Payable | $125M | $97M | $103M | $105M | $105M | $99M | $67M | $91M | $103M | $92M | $88M | $77M | · | $73M | $71M | $64M | |
| Accrued Liabilities | $94M | $93M | $72M | $63M | $77M | $86M | $62M | $87M | $97M | $114M | $98M | $89M | · | $87M | $94M | $94M | |
| Current Liabilities | $597M | $580M | $443M | $577M | $508M | $541M | $385M | $551M | $488M | $509M | $399M | $496M | · | $438M | $371M | $491M | |
| Capital Leases | $208M | $202M | $191M | $188M | $186M | $193M | $182M | $162M | $168M | $160M | $169M | $161M | · | $164M | $166M | $165M | |
| Deferred Tax | $62M | $59M | $57M | $53M | $32M | $34M | $32M | $30M | $30M | $29M | $27M | $26M | · | $27M | $27M | $26M | |
| Other Non-current Liabilities | $42M | $37M | $41M | $38M | $40M | $37M | $35M | $35M | $39M | $48M | $41M | $37M | · | $33M | $62M | $63M | |
| Total Liabilities | $1.57B | $1.37B | $1.24B | $1.41B | $1.32B | $1.36B | $1.28B | $1.43B | $1.37B | $1.39B | $1.33B | $1.42B | · | $1.36B | $1.32B | $1.49B | |
| Long-term Debt | $663M | $499M | $504M | $553M | $553M | $552M | $650M | $649M | $649M | $648M | $696M | $696M | · | $694M | $694M | $742M | |
| Total Debt | · | $499M | $504M | $553M | · | $552M | $650M | $649M | · | $648M | $696M | $696M | · | $694M | $694M | $742M | |
| Common Stock | $848.0K | $847.0K | $847.0K | $847.0K | $839.0K | $839.0K | $839.0K | $838.0K | $832.0K | $831.0K | $831.0K | $826.0K | · | $822.0K | $822.0K | $821.0K | |
| Retained Earnings | $3.03B | $2.96B | $2.92B | $2.84B | $2.78B | $2.72B | $2.66B | $2.59B | $2.54B | $2.49B | $2.45B | $2.41B | · | $2.38B | $2.35B | $2.33B | |
| Treasury Stock | $2.29B | $2.29B | $2.22B | $2.05B | $2.01B | $1.94B | $1.87B | $1.83B | $1.78B | $1.77B | $1.68B | $1.61B | · | $1.43B | $1.39B | $1.34B | |
| AOCI | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | · | $-2M | $-2M | $-2M | |
| Stockholders' Equity | $1.45B | $1.36B | $1.38B | $1.46B | $1.43B | $1.43B | $1.44B | $1.39B | $1.37B | $1.32B | $1.37B | $1.38B | $1.46B | $1.51B | $1.52B | $1.51B | |
| Liabilities + Equity | $3.01B | $2.74B | $2.61B | $2.87B | $2.75B | $2.79B | $2.72B | $2.82B | $2.74B | $2.72B | $2.70B | $2.79B | · | $2.87B | $2.84B | $3.00B | |
| Shares Outstanding | 34,033,000 | 34,023,000 | 34,654,000 | 36,324,000 | 35,952,000 | 36,512,000 | 37,289,000 | 37,716,000 | 37,681,000 | 37,765,000 | 39,526,000 | 40,401,000 | 82,232,000 | 44,232,000 | 45,443,000 | 45,396,000 |
现金流 14
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $10M | $10M | $13M | $8M | $10M | $10M | $11M | $9M | $7M | $6M | $6M | $7M | $3M | $3M | $2M | $6M | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $7M | $8M | $9M | $11M | $12M | $14M | $16M | $19M | |
| Restructuring | $1M | $863.0K | $4M | $310.0K | $388.0K | $510.0K | $322.0K | $2M | $653.0K | $473.0K | $68.0K | $676.0K | $1M | $1M | $1M | $15M | |
| Operating Cash Flow | $124M | $186M | $30M | $131M | $60M | $208M | $-19M | $89M | $60M | $143M | $-18M | $95M | $42M | $108M | $-50M | $91M | |
| CapEx | $27M | $20M | $15M | $16M | $19M | $10M | $11M | $10M | $17M | $2M | $5M | $10M | $7M | $9M | $4M | $5M | |
| Investing Cash Flow | $-28M | $-20M | $-20M | $-16M | $-12M | $-10M | $-11M | $-10M | $-16M | $-2M | $-5M | $-10M | $-7M | $44M | $-7M | $-6M | |
| Debt Issued | $163M | $617M | · | · | $0 | $0 | $0 | $10M | $0 | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | $0 | · | · | · | $0 | · | · | · | $-101M | |
| Stock Repurchased | $0 | $68M | $165M | $8M | $67M | $72M | $41M | $33M | $12M | $90M | $70M | $90M | $78M | · | · | $0 | |
| Net Stock Activity | · | · | · | $-8M | · | · | · | $-33M | · | · | · | $-90M | · | · | · | · | |
| Financing Cash Flow | $163M | $-76M | $-218M | $-50M | $-68M | $-172M | $-42M | $-34M | $-11M | $-140M | $-56M | $-95M | $-78M | $-44M | $-63M | $-103M | |
| Net Change in Cash | $259M | $90M | $-208M | $65M | $-20M | $26M | $-71M | $46M | $34M | $1M | $-78M | $-11M | $-42M | $107M | $-120M | $-18M | |
| Free Cash Flow | · | · | · | $115M | · | · | · | $79M | · | · | · | $85M | · | · | · | $86M | |
| Levered FCF | · | · | · | $106M | · | · | · | $67M | · | · | · | $72M | · | · | · | $71M |
盈利能力 7
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | 18.8% | 22.1% | 18.5% | · | 19.4% | 23.2% | 16.8% | · | 15.0% | 14.9% | 7.6% | · | 16.1% | 12.7% | 6.5% | |
| Net Margin | · | 8.6% | 15.2% | 13.4% | · | 13.1% | 16.9% | 11.1% | · | 8.9% | 10.1% | 2.9% | · | 12.4% | 6.7% | 0.62% | |
| Pretax Margin | · | 16.0% | 20.2% | 16.6% | · | 17.0% | 20.6% | 14.0% | · | 11.6% | 11.6% | 4.0% | · | 13.3% | 7.7% | 1.9% | |
| EBITDA Margin | · | 18.8% | 22.1% | 18.5% | · | 19.4% | 23.2% | 16.8% | · | 15.0% | 14.9% | 7.6% | · | 16.1% | 12.7% | 6.5% | |
| ROA | · | 1.5% | 2.9% | 2.2% | · | 2.2% | 2.8% | 1.7% | · | 1.3% | 1.4% | 0.37% | · | 1.4% | 0.74% | 0.06% | |
| ROE | · | 3.0% | 5.4% | 4.3% | · | 4.4% | 5.4% | 3.3% | · | 2.6% | 2.8% | 0.74% | · | 3.1% | 1.7% | 0.16% | |
| ROIC | · | 3.6% | 4.4% | 3.4% | · | 3.5% | 3.8% | 2.7% | · | 2.4% | 2.4% | 1.1% | · | 2.7% | 1.8% | 0.87% |
流动性与偿付能力 5
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 0.7 | 0.7 | 1.0 | · | 0.8 | 1.1 | 0.9 | · | 0.8 | 0.9 | 1.0 | · | 1.2 | 1.1 | 1.2 | |
| Quick Ratio | · | 0.6 | 0.5 | 0.8 | · | 0.7 | 0.9 | 0.8 | · | 0.6 | 0.8 | 0.8 | · | 1.0 | 0.8 | 0.9 | |
| Debt / Equity | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | |
| LT Debt / Equity | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | |
| Interest Coverage | · | 6.7 | 10.2 | 7.7 | · | 6.9 | 7.5 | 4.8 | · | 3.7 | 3.5 | 1.8 | · | 4.1 | 3.0 | 1.3 |
效率 2
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | |
| Receivables Turnover | · | 2.9 | 3.3 | 2.6 | · | 3.1 | 3.3 | 2.7 | · | 3.3 | 3.4 | 2.9 | · | 3.6 | 3.9 | 2.6 |
估值 (TTM) 13
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $1.92B | $1.88B | $1.79B | · | $1.74B | $1.67B | $1.59B | · | $1.54B | $1.49B | $1.46B | · | $1.45B | $1.44B | $1.45B | |
| Net Income TTM | · | $241M | $275M | $245M | · | $220M | $199M | $134M | · | $133M | $121M | $82M | · | $79M | $381M | $374M | |
| Market Cap | · | $3.92B | $3.59B | $5.61B | · | $3.67B | $3.39B | $2.85B | · | $1.94B | $2.33B | $1.73B | · | $1.71B | $1.61B | $1.65B | |
| Enterprise Value | · | $4.27B | $4.03B | $5.90B | · | $4.01B | $3.84B | $3.23B | · | $2.41B | $2.84B | $2.16B | · | $2.09B | $2.10B | $2.07B | |
| P/E | · | 17.5 | 14.1 | 24.1 | · | 17.7 | 17.9 | 22.6 | · | 16.3 | 21.4 | 23.9 | · | 22.5 | 4.6 | 4.8 | |
| P/S | · | 2.0 | 1.9 | 3.1 | · | 2.1 | 2.0 | 1.8 | · | 1.3 | 1.6 | 1.2 | · | 1.2 | 1.1 | 1.1 | |
| P/B | · | 2.9 | 2.6 | 3.8 | · | 2.6 | 2.4 | 2.0 | · | 1.5 | 1.7 | 1.3 | · | 1.1 | 1.1 | 1.1 | |
| P / Cash Flow | · | · | · | 43.0 | · | · | · | 31.9 | · | · | · | 17.4 | · | · | · | 18.1 | |
| P / FCF | · | · | · | 49.0 | · | · | · | 36.1 | · | · | · | 20.5 | · | · | · | 19.3 | |
| EV / EBITDA | · | 46.8 | 36.3 | 69.0 | · | 44.3 | 37.0 | 46.0 | · | 39.0 | 48.5 | 76.8 | · | 35.1 | 45.6 | 89.6 | |
| EV / FCF | · | · | · | 51.5 | · | · | · | 41.0 | · | · | · | 25.6 | · | · | · | 24.1 | |
| EV / Revenue | · | 2.2 | 2.1 | 3.3 | · | 2.3 | 2.3 | 2.0 | · | 1.6 | 1.9 | 1.5 | · | 1.4 | 1.5 | 1.4 | |
| Earnings Yield | · | 5.7% | 7.1% | 4.2% | · | 5.6% | 5.6% | 4.4% | · | 6.2% | 4.7% | 4.2% | · | 4.5% | 21.9% | 20.8% |
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
损益表
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| 收入 | $1.95B | $1.79B | $1.58B | $1.45B | — |
| 营业利润率 % | 19.6% | 19.1% | 13.7% | 11.6% | — |
| 净收入 | $252M | $237M | $137M | $93M | — |
| 稀释后每股收益 (EPS) | $7.04 | $6.18 | $3.39 | $2.05 | — |
资产负债表
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.5 | 0.4 | 0.5 | 0.5 | — |
| 流动比率 | 1.1 | 0.8 | 0.9 | 1.1 | — |
| 速动比率 | 1.0 | 0.7 | 0.7 | 0.9 | — |
现金流
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $393M | $288M | $247M | $166M | — |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存,并会跟随您浏览所有股票。
机构持有人 (13F) 403 家申报者 · $3.0B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 61 (+15 与上一季度对比) | 30 (-23 与上一季度对比) | 137 (+3 与上一季度对比) | 121 (-7 与上一季度对比) | +4.5M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
公司内部人士 111 位内幕人士 · 46 位高管 · 24 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Daniel Hamburger | President and CEO | 2015年8月31日 S | 142136 | 0 | 0 | $0 |
| Michael O Randolfi | SVP, Chief Financial Officer | 2020年8月28日 F | 84391 | 0 | 0 | $0 |
| Timothy J Wiggins | SVP & Chief Financial Officer | 2016年2月25日 S | 44939 | 0 | 0 | $0 |
| Richard Gunst | Chief Financial Officer | 2012年2月1日 M | 9356 | 0 | 0 | $0 |
| Amelia Manning | President, Chamberlain Univ. | 2026年7月15日 A | 4317 | 0 | 0 | $0 |
| Karen Sue Cox | President, Chamberlain Univ. | 2026年5月8日 S | 31596 | 0 | 1 | $-249000 |
| Scott Liles | President, Medical and Vet | 2026年4月15日 F | 13103 | 0 | 0 | $0 |
| Evan Trent | President, Adtalem Elevate | 2025年11月13日 F | 24134 | 0 | 0 | $0 |
| Thiago Aguiar Sayao | Group President, Business &Law | 2020年2月28日 S | 1830 | 0 | 0 | $0 |
| Carlos Filgueiras | Group President, Tech/Business | 2019年2月13日 S | 11775 | 0 | 0 | $0 |
| Donna M Loraine | President, Carrington Colleges | 2018年11月6日 M | 6701 | 0 | 0 | $0 |
| Susan Groenwald | President, Chamberlain | 2018年2月9日 M | 34402 | 0 | 0 | $0 |
| John P Roselli | President, Becker Professional | 2017年9月1日 S | 13730 | 0 | 0 | $0 |
| Eric P. Dirst | President, ATGE Shared Ops | 2017年8月31日 S | 14800 | 0 | 0 | $0 |
| Robert A Paul | President, DeVry University | 2017年8月25日 M | 28426 | 0 | 0 | $0 |
| Steven Riehs | President, Med, Prof & Online | 2016年9月2日 M | 28062 | 0 | 0 | $0 |
| Jeffrey Richard Akens | President, Carrington College | 2015年8月29日 F | 6752 | 0 | 0 | $0 |
| Christopher Caywood | President, Online Services | 2013年3月1日 F | 7378 | 0 | 0 | $0 |
| Andrew A Jeon | President, DeVry Medical Int'l | 2012年11月2日 F | 5655 | 0 | 0 | $0 |
| William B. Hughson | President, Medical & | 2012年8月29日 A | 2143 | 0 | 0 | $0 |
| Manjunath Gangadharan | VP, Chief Accounting Officer | 2026年5月18日 F | 5271 | 0 | 1 | $-128072 |
| Michael Betz | Pres. Walden University & CDO | 2025年11月13日 F | 33286 | 0 | 0 | $0 |
| Maurice Herrera | SVP - Chief Marketing Officer | 2025年11月13日 F | 20584 | 0 | 0 | $0 |
| Megan Noel | Chief Corp. Affairs Officer | 2025年11月12日 A | 2226 | 0 | 0 | $0 |
| Sara Hill | CHRO | 2025年11月12日 A | 10276 | 0 | 0 | $0 |
| Blake Simpson | SVP, Chief Comms & CA Officer | 2024年12月5日 F | 8795 | 0 | 0 | $0 |
| Steven Tom | SVP Chief Customer Officer | 2024年11月13日 A | 13255 | 0 | 0 | $0 |
| Cheryl James | SVP, CHRO | 2024年2月28日 F | 17485 | 0 | 0 | $0 |
| John W Danaher MD | Pres. - Adtalem Med & Vet | 2023年8月25日 F | 38718 | 0 | 0 | $0 |
| James Raymond Bartholomew | SVP - Chamberlain University | 2022年8月26日 F | 6418 | 0 | 0 | $0 |
| Holland Katherine Alice Boden | Group Pres, Adtalem Health | 2021年8月30日 F | 32148 | 0 | 0 | $0 |
| Fernando Lau | SVP, Chief Marketing Officer | 2021年8月28日 F | 19253 | 0 | 0 | $0 |
| Christopher C Nash | SVP, Chief Information Officer | 2021年8月28日 F | 25741 | 0 | 0 | $0 |
| Donna Jennings | SVP, Human Resources | 2021年8月28日 F | 30898 | 0 | 0 | $0 |
| Chaka M Patterson | SVP and General Counsel | 2020年8月28日 F | 5202 | 0 | 0 | $0 |
| Mehul R Patel | Group Pres, Financial Services | 2019年11月7日 F | 11258 | 0 | 0 | $0 |
| Kathleen Carroll | Vice President, Controller | 2019年8月28日 A | 5497 | 0 | 0 | $0 |
| Lisa M Sodeika | SVP, Corporate Affairs | 2019年8月28日 A | 24151 | 0 | 0 | $0 |
| Patrick J Unzicker | Principal Financial Officer | 2019年8月27日 F | 36360 | 0 | 0 | $0 |
| Catherine C. Anderson | SVP, Strategy & Innovation | 2019年8月26日 F | 6025 | 0 | 0 | $0 |
| Gena L Ashe | SVP, CLO and Secretary | 2017年8月23日 A | 4420 | 0 | 0 | $0 |
| Gregory S Davis | SVP and General Counsel | 2016年9月1日 S | 22433 | 0 | 0 | $0 |
| Adriano Allegrini | VP, Strategy and Bus. Develop. | 2015年8月29日 F | 7004 | 0 | 0 | $0 |
| Sharon Thomas Parrott | SVP, Gov. & Regulatory Affairs | 2014年11月5日 A | 5610 | 0 | 0 | $0 |
| David J Pauldine | Executive Vice President & | 2014年4月25日 M | 30242 | 0 | 0 | $0 |
| Thomas C Shepherd | Executive Vice President and | 2011年5月27日 M | 0 | 0 | 0 | $0 |
| Michael W Malafronte | 董事 | 2026年3月11日 P | 25395 | 5 | 0 | $3844716 |
| William V Krehbiel | 董事 | 2025年11月13日 F | 16303 | 0 | 0 | $0 |
| Betty M. Vandenbosch | 董事 | 2025年11月13日 F | 2584 | 0 | 0 | $0 |
| Kenneth J Phelan | 董事 | 2025年11月13日 F | 19836 | 1 | 0 | $49931 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| International Value Advisers, LLC, Charles de Vaulx ×18 申报 | 2020年8月7日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 79 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| PSCD · Invesco Exchange-Traded Fund Trus... | 1.82% | 3165 SH | 2026年8月8日 | 每日 |
| PSL · Invesco Exchange-Traded Fund Trust | 1.76% | 10579 SH | 2026年8月8日 | 每日 |
| MYLD · Cambria ETF Trust | 0.94% | 2418 NS | 2026年4月30日 | N-PORT |
| XSHQ · Invesco Exchange-Traded Fund Trus... | 0.91% | 20685 SH | 2026年8月8日 | 每日 |
| RZG · Invesco Exchange-Traded Fund Trust | 0.88% | 8705 SH | 2026年8月8日 | 每日 |
| CGMM · Capital Group Equity ETF Trust I | 0.80% | 190016 NS | 2026年5月31日 | N-PORT |
| VUSE · ETF Series Solutions | 0.53% | 31159 NS | 2026年5月31日 | N-PORT |
| IJT · iShares Trust | 0.47% | 316256 SH | 2026年8月8日 | 每日 |
| CAFG · Pacer Funds Trust | 0.47% | 919 NS | 2026年4月30日 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.46% | 40509 SH | 2026年8月8日 | 每日 |
| CALF · Pacer Funds Trust | 0.46% | 136827 NS | 2026年4月30日 | N-PORT |
| FYC · First Trust Exchange-Traded Alpha... | 0.33% | 29825 NS | 2026年4月30日 | N-PORT |
| QVMS · Invesco Exchange-Traded Fund Trus... | 0.27% | 4982 SH | 2026年8月8日 | 每日 |
| XJR · iShares Trust | 0.26% | 4021 SH | 2026年8月8日 | 每日 |
| IWO · iShares Trust | 0.26% | 312826 SH | 2026年8月8日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.26% | 52359 SH | 2026年8月8日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.25% | 36861 SH | 2026年8月8日 | 每日 |
| IJR · iShares Trust | 0.23% | 2075461 SH | 2026年8月8日 | 每日 |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.23% | 119030 SH | 2026年8月8日 | 每日 |
| JPSE · J.P. Morgan Exchange-Traded Fund ... | 0.21% | 10711 NS | 2026年4月30日 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Inde... | 0.21% | 4228 SH | 2026年8月8日 | 每日 |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.21% | 13071 NS | 2026年4月30日 | N-PORT |
| SMDX · Tidal Trust III | 0.20% | 2228 NS | 2026年4月30日 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.20% | 46807 NS | 2026年5月31日 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0.18% | 1290 NS | 2026年4月30日 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.18% | 217961 NS | 2026年4月30日 | N-PORT |
| SAA · ProShares Trust | 0.18% | 412 NS | 2026年5月31日 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.14% | 29761 NS | 2026年4月30日 | N-PORT |
| GMOV · GMO ETF Trust | 0.14% | 1078 NS | 2026年5月31日 | N-PORT |
| IWM · iShares Trust | 0.13% | 875500 SH | 2026年8月8日 | 每日 |
| ISCG · iShares Trust | 0.13% | 10563 SH | 2026年8月8日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.13% | 198216 SH | 2026年8月8日 | 每日 |
| FNDA · SCHWAB STRATEGIC TRUST | 0.13% | 98138 NS | 2026年5月31日 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trus... | 0.13% | 19006 SH | 2026年8月8日 | 每日 |
| SMLF · iShares Trust | 0.12% | 41596 SH | 2026年8月8日 | 每日 |
| VFQY · VANGUARD WELLINGTON FUND | 0.12% | 4599 SH | 2026年8月8日 | 每日 |
| PKW · Invesco Exchange-Traded Fund Trust | 0.12% | 15066 SH | 2026年8月8日 | 每日 |
| VCR · VANGUARD WORLD FUND | 0.12% | 67714 SH | 2026年8月8日 | 每日 |
| RSSL · Global X Funds | 0.12% | 14797 NS | 2026年4月30日 | N-PORT |
| FYX · First Trust Exchange-Traded Alpha... | 0.11% | 12017 NS | 2026年4月30日 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.11% | 9365 NS | 2026年5月31日 | N-PORT |
| FDIS · FIDELITY COVINGTON TRUST | 0.10% | 15550 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.10% | 1606 NS | 2026年5月31日 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0.10% | 5421 SH | 2026年8月8日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.09% | 111249 NS | 2026年4月30日 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.09% | 470701 SH | 2026年8月8日 | 每日 |
| SCHA · SCHWAB STRATEGIC TRUST | 0.09% | 165865 NS | 2026年5月31日 | N-PORT |
| ESML · iShares Trust | 0.07% | 16803 SH | 2026年8月8日 | 每日 |
| FAD · First Trust Exchange-Traded Alpha... | 0.07% | 2779 NS | 2026年4月30日 | N-PORT |
| ISCB · iShares Trust | 0.06% | 1479 SH | 2026年8月8日 | 每日 |